Nifty

:

19664.70

Sensex

:

65945.47

-9.85 (-0.05%)
-78.22 (-0.12%)

Login

Nifty
Sensex

:
:

19664.70
65945.47

-9.85 (-0.05%)
-78.22 (-0.12%)

Ind-Swift Ltd.

Pharmaceuticals & Drugs

Rating :

57/99

BSE: 524652 | NSE: INDSWFTLTD

Watchlist

NSE BSE

20.70

26-Sep-2023

Open
High
Low
Previous Close

20.70
20.70
20.70
21.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

772
0.16
23.75
6.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

110.44
2.52
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,129.91
N/A
-0.17

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

0.12
8.07
-3.93

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
48.45
14.21

PAT CAGR (%)

10 Years
5 Years
3 Years

-15.76
-18.04
-35.31

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-0.02
-0.02
-0.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

36.98
49.73
48.45

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var%
Net Sales 148.54 94.67 56.90% 105.88 105.57 0.29% 106.59 104.35 2.15% 103.82 97.38 6.61%
Expenses 130.14 89.55 45.33% 97.92 95.59 2.44% 88.69 92.32 -3.93% 92.90 84.69 9.69%
EBITDA 18.40 5.13 258.67% 7.95 9.98 -20.34% 17.89 12.03 48.71% 10.92 12.69 -13.95%
EBIDTM 12.39% 5.41% 7.51% 9.45% 16.79% 11.53% 10.52% 13.03%
Other Income 5.63 1.51 272.85% 6.28 7.08 -11.30% 3.20 3.33 -3.90% 1.00 5.62 -82.21%
Interest 14.94 15.06 -0.80% 14.48 14.24 1.69% 14.84 14.14 4.95% 15.38 15.30 0.52%
Depreciation 6.72 7.01 -4.14% 7.24 8.30 -12.77% 7.29 7.99 -8.76% 7.13 7.95 -10.31%
PBT 2.36 -15.44 - 53.10 -5.48 - -1.03 -6.04 - -10.59 -4.94 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 2.36 -15.44 - 53.10 -5.48 - -1.03 -6.04 - -10.59 -4.94 -
PATM 1.59% -16.31% 50.15% -5.19% -0.97% -5.78% -10.20% -5.07%
EPS 0.44 -2.85 - 9.80 -1.01 - -0.19 -1.11 - -1.95 -0.91 -

Description Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var%
Net Sales 148.54 94.67 56.90% 105.88 105.57 0.29% 106.59 104.35 2.15% 103.82 97.38 6.61%
Expenses 130.14 89.55 45.33% 97.92 95.59 2.44% 88.69 92.32 -3.93% 92.90 84.69 9.69%
EBITDA 18.40 5.13 258.67% 7.95 9.98 -20.34% 17.89 12.03 48.71% 10.92 12.69 -13.95%
EBIDTM 12.39% 5.41% 7.51% 9.45% 16.79% 11.53% 10.52% 13.03%
Other Income 5.63 1.51 272.85% 6.28 7.08 -11.30% 3.20 3.33 -3.90% 1.00 6.37 -84.30%
Interest 14.94 15.06 -0.80% 14.48 14.24 1.69% 14.84 14.14 4.95% 15.38 16.04 -4.11%
Depreciation 6.72 7.01 -4.14% 7.24 8.30 -12.77% 7.29 7.99 -8.76% 7.13 7.95 -10.31%
PBT 2.36 -15.44 - 53.10 -5.48 - -1.03 -6.77 - -10.59 -4.94 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 2.36 -15.44 - 53.10 -5.48 - -1.03 -6.77 - -10.59 -4.94 -
PATM 1.59% -16.31% 50.15% -5.19% -0.97% -6.49% -10.20% -5.07%
EPS 0.44 -2.85 - 9.80 -1.01 - -0.19 -1.25 - -1.96 -0.91 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 464.83 397.71 356.06 329.52 289.03 269.81 263.05 304.33 417.17 569.80 393.12 Net Sales Growth 15.64% 11.70% 8.05% 14.01% 7.12% 2.57% -13.56% -27.05% -26.79% 44.94% Cost Of Goods Sold 255.87 211.03 186.53 187.73 159.95 154.15 166.03 220.48 353.43 458.49 287.85 Gross Profit 208.96 186.69 169.53 141.79 129.08 115.66 97.03 83.85 63.74 111.31 105.27 GP Margin 44.95% 46.94% 47.61% 43.03% 44.66% 42.87% 36.89% 27.55% 15.28% 19.53% 26.78% Total Expenditure 409.65 352.36 314.68 306.18 278.28 263.52 328.46 461.28 487.10 603.92 415.52 Power & Fuel Cost - 10.62 9.34 12.40 13.00 11.10 10.43 10.89 11.80 13.57 9.07 % Of Sales - 2.67% 2.62% 3.76% 4.50% 4.11% 3.97% 3.58% 2.83% 2.38% 2.31% Employee Cost - 57.75 51.17 48.93 46.33 44.67 38.79 36.77 39.27 45.13 40.82 % Of Sales - 14.52% 14.37% 14.85% 16.03% 16.56% 14.75% 12.08% 9.41% 7.92% 10.38% Manufacturing Exp. - 28.90 20.76 16.04 14.45 12.93 9.53 8.58 11.67 26.39 20.37 % Of Sales - 7.27% 5.83% 4.87% 5.00% 4.79% 3.62% 2.82% 2.80% 4.63% 5.18% General & Admin Exp. - 35.69 30.14 30.98 26.37 25.28 63.95 50.40 25.18 24.69 23.04 % Of Sales - 8.97% 8.46% 9.40% 9.12% 9.37% 24.31% 16.56% 6.04% 4.33% 5.86% Selling & Distn. Exp. - 5.50 9.97 7.31 6.83 3.15 3.50 4.16 11.47 19.83 18.35 % Of Sales - 1.38% 2.80% 2.22% 2.36% 1.17% 1.33% 1.37% 2.75% 3.48% 4.67% Miscellaneous Exp. - 2.88 6.78 2.79 11.35 12.23 36.24 130.01 34.29 15.83 18.35 % Of Sales - 0.72% 1.90% 0.85% 3.93% 4.53% 13.78% 42.72% 8.22% 2.78% 4.08% EBITDA 55.16 45.35 41.38 23.34 10.75 6.29 -65.41 -156.95 -69.93 -34.12 -22.40 EBITDA Margin 11.87% 11.40% 11.62% 7.08% 3.72% 2.33% -24.87% -51.57% -16.76% -5.99% -5.70% Other Income 16.11 23.55 15.22 22.38 8.44 14.57 13.68 12.51 1.87 12.80 6.34 Interest 59.64 57.16 52.18 35.19 3.77 11.46 16.32 18.97 39.93 76.76 86.41 Depreciation 28.38 32.07 32.70 33.59 33.97 34.63 35.73 36.35 39.36 26.26 18.48 PBT 43.84 -20.34 -28.29 -23.06 -18.55 -25.23 -103.77 -199.77 -147.36 -124.34 -120.94 Tax 0.00 0.42 0.32 2.46 0.00 0.75 0.89 0.17 -2.23 -8.77 -9.65 Tax Rate 0.00% -2.14% -1.08% -14.77% 0.00% -1.41% -0.24% -0.09% 1.51% 7.05% 7.98% PAT 43.84 -20.02 -29.82 -19.12 8.19 -54.13 -364.27 -199.94 -145.13 -115.56 -111.29 PAT before Minority Interest 43.84 -20.02 -29.82 -19.12 8.19 -54.13 -364.27 -199.94 -145.13 -115.56 -111.29 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.43% -5.03% -8.37% -5.80% 2.83% -20.06% -138.48% -65.70% -34.79% -20.28% -28.31% PAT Growth 237.43% - - - - - - - - - EPS 8.09 -3.69 -5.50 -3.53 1.51 -9.99 -67.21 -36.89 -26.78 -21.32 -20.53

Description TTM Mar 18 Mar 17 Mar 16
Net Sales 464.83 269.81 263.05 304.33 Net Sales Growth 15.64% 2.57% -13.56% Cost Of Goods Sold 255.87 154.15 166.03 220.48 Gross Profit 208.96 115.66 97.03 83.85 GP Margin 44.95% 42.87% 36.89% 27.55% Total Expenditure 409.65 263.52 328.46 461.28 Power & Fuel Cost - 11.10 10.43 10.89 % Of Sales - 4.11% 3.97% 3.58% Employee Cost - 44.67 38.79 36.77 % Of Sales - 16.56% 14.75% 12.08% Manufacturing Exp. - 12.93 9.53 8.58 % Of Sales - 4.79% 3.62% 2.82% General & Admin Exp. - 25.28 63.95 50.40 % Of Sales - 9.37% 24.31% 16.56% Selling & Distn. Exp. - 3.15 3.50 4.16 % Of Sales - 1.17% 1.33% 1.37% Miscellaneous Exp. - 12.23 36.24 130.01 % Of Sales - 4.53% 13.78% 42.72% EBITDA 55.16 6.29 -65.41 -156.95 EBITDA Margin 11.87% 2.33% -24.87% -51.57% Other Income 16.11 14.57 13.68 12.51 Interest 59.64 11.46 16.32 18.97 Depreciation 28.38 34.63 35.73 36.35 PBT 43.84 -25.23 -103.77 -199.77 Tax 0.00 0.75 0.89 0.17 Tax Rate 0.00% -1.41% -0.24% -0.09% PAT 43.84 -54.13 -364.27 -199.94 PAT before Minority Interest 43.84 -54.13 -364.27 -199.94 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 9.43% -20.06% -138.48% -65.70% PAT Growth 234.35% - - EPS 8.09 -9.99 -67.21 -36.89

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds -720.32 -695.16 -713.12 -676.74 -679.37 -611.01 -239.48 -39.50 108.38 217.30 Share Capital 10.83 10.83 10.83 10.83 10.83 25.03 24.27 24.27 24.27 23.44 Total Reserves -731.15 -706.00 -723.95 -687.57 -690.20 -636.04 -270.43 -70.45 77.43 186.57 Non-Current Liabilities 634.49 660.58 660.64 659.29 693.89 672.22 679.33 549.04 595.58 609.48 Secured Loans 555.04 629.97 624.94 620.34 651.65 644.57 647.04 507.75 542.99 556.26 Unsecured Loans 64.26 14.20 19.28 24.34 29.54 20.20 24.61 33.66 42.11 34.37 Long Term Provisions 8.00 9.04 8.72 7.36 5.66 2.64 2.04 1.40 1.60 0.96 Current Liabilities 717.59 706.16 654.13 615.87 598.24 607.85 620.93 718.29 685.84 580.56 Trade Payables 203.91 232.02 226.22 198.83 180.12 161.76 175.38 150.26 191.35 140.96 Other Current Liabilities 146.98 98.28 57.34 53.16 44.08 62.57 74.30 199.01 147.45 87.41 Short Term Borrowings 365.51 375.86 370.56 363.88 374.04 383.52 371.25 369.02 347.05 352.19 Short Term Provisions 1.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Total Liabilities 631.76 671.58 601.65 598.42 612.76 669.06 1,060.78 1,227.83 1,389.80 1,407.34 Net Block 235.50 244.01 269.66 290.56 310.68 342.31 374.14 403.66 440.12 420.66 Gross Block 630.13 607.40 601.49 589.92 576.33 576.38 572.52 565.68 559.58 513.99 Accumulated Depreciation 394.63 363.39 331.83 299.37 265.65 234.06 198.37 162.02 119.45 93.33 Non Current Assets 389.31 406.40 373.00 404.91 426.66 462.63 439.25 468.93 505.95 519.41 Capital Work in Progress 9.00 13.06 0.00 0.00 0.00 2.22 3.67 3.89 4.44 36.85 Non Current Investment 64.35 70.31 24.06 41.26 43.91 43.90 45.12 45.12 45.19 45.19 Long Term Loans & Adv. 80.46 79.02 79.27 73.09 72.06 74.19 16.31 16.26 16.20 16.71 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 242.44 265.17 228.65 193.51 186.11 206.43 611.65 737.94 851.09 842.83 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 69.58 62.85 52.41 49.00 45.44 39.06 90.94 113.37 253.36 329.46 Sundry Debtors 90.62 107.95 94.17 75.56 83.50 108.48 380.33 485.48 440.14 363.98 Cash & Bank 16.18 28.99 16.76 19.72 3.68 9.11 17.39 16.98 17.90 17.79 Other Current Assets 66.06 19.48 19.05 2.07 53.49 49.78 122.98 122.11 139.70 131.60 Short Term Loans & Adv. 46.65 45.91 46.27 47.17 51.48 42.81 109.93 108.90 123.33 115.90 Net Current Assets -475.15 -440.99 -425.48 -422.36 -412.13 -401.42 -9.29 19.65 165.25 262.27 Total Assets 631.75 671.57 601.65 598.42 612.77 669.06 1,060.79 1,227.83 1,389.81 1,407.36

Description Mar 18 Mar 17 Mar 16
Shareholder's Funds -663.18 -615.50 -245.43 Share Capital 25.03 25.03 24.27 Total Reserves -688.21 -640.54 -276.38 Non-Current Liabilities 679.69 672.22 679.33 Secured Loans 651.65 644.57 647.04 Unsecured Loans 15.34 20.20 24.61 Long Term Provisions 5.66 2.64 2.04 Current Liabilities 598.24 607.85 620.93 Trade Payables 166.30 161.76 175.38 Other Current Liabilities 57.90 62.57 74.30 Short Term Borrowings 374.04 383.52 371.25 Short Term Provisions 0.00 0.00 0.00 Total Liabilities 614.75 664.57 1,054.83 Net Block 310.68 342.31 374.14 Gross Block 576.33 576.38 572.52 Accumulated Depreciation 265.65 234.06 198.37 Non Current Assets 428.64 458.13 433.29 Capital Work in Progress 0.00 2.22 3.67 Non Current Investment 45.90 39.41 39.17 Long Term Loans & Adv. 72.06 74.19 16.31 Other Non Current Assets 0.00 0.00 0.00 Current Assets 186.11 206.43 611.65 Current Investments 0.00 0.00 0.00 Inventories 45.44 39.06 90.94 Sundry Debtors 83.50 108.48 380.33 Cash & Bank 3.68 9.11 17.39 Other Current Assets 53.49 6.97 13.05 Short Term Loans & Adv. 47.82 42.81 109.93 Net Current Assets -412.13 -401.42 -9.29 Total Assets 614.75 664.56 1,054.83

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 89.63 83.19 34.60 42.79 1.34 6.72 -105.79 85.57 102.73 -146.30 PBT -20.34 -28.29 -19.12 8.19 -53.38 -363.37 -199.77 -147.36 -124.34 -120.94 Adjustment 78.37 88.12 52.68 21.32 73.12 321.14 168.51 90.75 107.10 112.62 Changes in Working Capital 32.01 23.68 1.03 13.27 -18.41 48.95 -74.54 142.19 120.11 -138.18 Cash after chg. in Working capital 90.04 83.52 34.60 42.79 1.34 6.72 -105.79 85.57 102.87 -146.50 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.42 -0.32 0.00 0.00 0.00 0.00 0.00 0.00 -0.13 0.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -18.42 -16.71 -11.35 -13.71 -2.73 -4.30 -4.01 -5.52 -13.76 -27.72 Net Fixed Assets -18.67 -18.97 -11.57 -13.59 2.27 -2.41 -6.62 -5.55 -13.18 -28.35 Net Investments 5.96 -46.25 17.20 2.65 -0.01 1.22 0.00 0.07 0.00 0.38 Others -5.71 48.51 -16.98 -2.77 -4.99 -3.11 2.61 -0.04 -0.58 0.25 Cash from Financing Activity -84.02 -54.25 -26.20 -13.03 -4.04 -10.71 110.21 -80.97 -88.87 146.22 Net Cash Inflow / Outflow -12.81 12.23 -2.96 16.05 -5.43 -8.28 0.41 -0.91 0.11 -27.81 Opening Cash & Equivalents 28.99 16.76 19.72 3.68 9.11 17.39 16.98 17.90 17.79 45.60 Closing Cash & Equivalent 16.18 28.99 16.76 19.72 3.68 9.11 17.39 16.98 17.90 17.79

Description Mar 18 Mar 17 Mar 16
Cash From Operating Activity 7.17 -1.72 -119.44 PBT -50.43 -371.81 -213.42 Adjustment 73.87 321.14 168.51 Changes in Working Capital -16.28 48.95 -74.54 Cash after chg. in Working capital 7.17 -1.72 -119.44 Interest Paid 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -6.42 4.14 9.64 Net Fixed Assets 2.27 -2.41 Net Investments -0.01 1.22 Others -8.68 5.33 Cash from Financing Activity -6.17 -10.71 110.21 Net Cash Inflow / Outflow -5.43 -8.28 0.41 Opening Cash & Equivalents 9.11 17.39 16.98 Closing Cash & Equivalent 3.68 9.11 17.39

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) -132.99 -128.34 -131.66 -124.94 -125.43 -115.43 -53.68 -16.16 10.87 32.63 ROA -3.07% -4.68% -3.19% 1.35% -8.45% -42.12% -17.47% -11.09% -8.26% -7.48% ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -112.51% -55.75% ROCE 11.69% 7.19% 5.82% 3.37% -10.31% -56.22% -20.35% -10.41% -4.27% -3.10% Fixed Asset Turnover 0.65 0.61 0.57 0.50 0.47 0.47 0.54 0.75 1.07 0.80 Receivable days 89.66 100.13 91.72 100.44 129.49 333.86 513.44 400.24 255.51 374.10 Inventory Days 59.80 57.10 54.80 59.63 56.99 88.79 121.16 158.57 185.19 319.31 Payable days 377.00 448.35 247.87 248.96 230.73 227.19 184.88 167.49 116.11 212.80 Cash Conversion Cycle -227.55 -291.13 -101.35 -88.90 -44.24 195.46 449.72 391.32 324.59 480.61 Total Debt/Equity -1.44 -1.47 -1.43 -1.49 -1.55 -1.72 -4.09 -15.49 14.65 5.89 Interest Cover 0.66 0.43 0.53 3.18 -3.66 -21.27 -9.53 -2.69 -0.62 -0.40

Description Mar 18 Mar 17 Mar 16
Book Value (Rs.) -125.06 -116.26 -54.86 ROA -8.46% -42.37% -18.95% ROE 0.00% 0.00% 0.00% ROCE -10.34% -56.70% -22.84% Fixed Asset Turnover 0.47 0.47 0.54 Receivable days 129.49 333.86 451.08 Inventory Days 56.99 88.79 107.86 Payable days 221.40 227.19 199.14 Cash Conversion Cycle -34.91 195.46 359.81 Total Debt/Equity -1.57 -1.70 -4.00 Interest Cover -3.66 -21.27 -9.53

Top Investors:

sharwan singh guleria

rameshkumar javerchand jain

justin pharmaceuticals private limited

deepa ram kheria

gravity systems private limited

panchkula finvest private limited

excel motors private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback